4-((2-Oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-N-(3-(trifluoromethyl)benzyl)benzamide

Catalog No. :
ACVKWF784
CAS No. :
339025-40-0
Molecular Formula :
C22H16F6N2O2
Molecular Weight :
454.37

IUPAC Name:4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-N-(3-(trifluoromethyl)benzyl)benzamide

4-((2-Oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-N-(3-(trifluoromethyl)benzyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((2-Oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-N-(3-(trifluoromethyl)benzyl)benzamide
IUPAC Name4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-N-(3-(trifluoromethyl)benzyl)benzamide
Molecular FormulaC22H16F6N2O2
Molecular Weight454.37
SMILESO=C(NCC1=CC=CC(C(F)(F)F)=C1)C2=CC=C(CN3C=C(C(F)(F)F)C=CC3=O)C=C2
InChI KeyKVKJBLYSIAIMLK-UHFFFAOYSA-N
Synonym4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}-N-{[3-(trifluoromethyl)phenyl]methyl}benzamide;4-([2-OXO-5-(TRIFLUOROMETHYL)-1(2H)-PYRIDINYL]METHYL)-N-[3-(TRIFLUOROMETHYL)BENZYL]BENZENECARBOXAMIDE;Benzamide, 4-[[2-oxo-5-(trifluoromethyl)-1(2H)-pyridinyl]methyl]-N-[[3-(trifluoromethyl)phenyl]methyl]-
CAS No.339025-40-0

Synthetic Route by SureRoute

1. ACVKWF784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVKWF784 route product structure diagram
    ACVKWF784339025-40-0
Inquiry

2. ACVKWF784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPVGH896 route compound structure diagram
    ACPVGH89633252-63-0 In Stock
  4. Then
  5. ACVKWF784 route product structure diagram
    ACVKWF784339025-40-0
Inquiry

Comments (0)